HYDERABAD: Bharat Biotech on Friday announced the temporary slowing down of production of its Covid-19 vaccine Covaxin across its manufacturing facilities as it has completed its supply obligations. The company also said that it expected a decrease in demand for the indigenous vaccine.
The Hyderabad-based vaccine maker said that for the coming period, the company will focus on pending facility maintenance, process and facility optimisation. Sources said that the company had hit a peak of about 8 crore doses of Covaxin every month in early 2022.